TY - JOUR
T1 - Plasma lactate and diabetes risk in 8045 participants of the Atherosclerosis Risk in Communities Study
AU - Juraschek, Stephen P.
AU - Selvin, Elizabeth
AU - Miller, Edgar R.
AU - Brancati, Frederick L.
AU - Young, J. Hunter
N1 - Funding Information:
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts ( HHSN268201100005C , HHSN268201100006C , HHSN268201100007C , HHSN268201100008C , HHSN268201100009C , HHSN268201100010C , HHSN268201100011C , and HHSN268201100012C ).
Funding Information:
Funding: This work was supported by P60 Diabetes P&C Core of the Diabetes Research Training Center ( 5P60DK079637-04 ). Dr. J.H.Y. and Dr. E.S. were supported by NIH/NHLBI ( RO1DK085458 ) grant. S.P.J. was supported by NIH/NHLBI T32HL007024 Cardiovascular Epidemiology Training Grant .
PY - 2013/12
Y1 - 2013/12
N2 - Purpose: Determinants of oxidative capacity, such as fitness and level of adiposity, are strongly associated with type 2 diabetes. Whether decreased oxidative capacity itself is a cause or consequence of insulin resistance and diabetes is unknown. Methods: We examined the association of plasma lactate, a marker of oxidative capacity, with incident diabetes in 8045 participants from the Atherosclerosis Risk in Communities (ARIC) Study with no history of subclinical or diagnosed diabetes at baseline (1996-1998). Incident diabetes was self-reported during annual telephone calls. Results: During a median follow-up of 12 years, there were 1513 new cases of diabetes. In Cox proportional hazards models, baseline plasma lactate (per 10 mg/dL) was significantly associated with diabetes (hazard ratio, 1.20; 95% confidence interval, 1.01-1.43), even after adjustment for diabetes risk factors, fasting glucose, and insulin. The upper quartile of baseline lactate (ge;8.1 mg/dL) was also significantly associated with diabetes risk (hazard ratio, 1.20; 95% confidence interval, 1.02-1.41) compared with the lowest quartile (≤5.1 mg/dL). Significant associations persisted among persons without insulin resistance (homeostatic model assessment insulin resistance index < 2.6 U) (P-trend < .01). Conclusions: These findings suggest that low oxidative capacity may precede diabetes. Future studies should evaluate the physiological origins of elevated lactate to better understand its possible role in the pathogenesis of diabetes.
AB - Purpose: Determinants of oxidative capacity, such as fitness and level of adiposity, are strongly associated with type 2 diabetes. Whether decreased oxidative capacity itself is a cause or consequence of insulin resistance and diabetes is unknown. Methods: We examined the association of plasma lactate, a marker of oxidative capacity, with incident diabetes in 8045 participants from the Atherosclerosis Risk in Communities (ARIC) Study with no history of subclinical or diagnosed diabetes at baseline (1996-1998). Incident diabetes was self-reported during annual telephone calls. Results: During a median follow-up of 12 years, there were 1513 new cases of diabetes. In Cox proportional hazards models, baseline plasma lactate (per 10 mg/dL) was significantly associated with diabetes (hazard ratio, 1.20; 95% confidence interval, 1.01-1.43), even after adjustment for diabetes risk factors, fasting glucose, and insulin. The upper quartile of baseline lactate (ge;8.1 mg/dL) was also significantly associated with diabetes risk (hazard ratio, 1.20; 95% confidence interval, 1.02-1.41) compared with the lowest quartile (≤5.1 mg/dL). Significant associations persisted among persons without insulin resistance (homeostatic model assessment insulin resistance index < 2.6 U) (P-trend < .01). Conclusions: These findings suggest that low oxidative capacity may precede diabetes. Future studies should evaluate the physiological origins of elevated lactate to better understand its possible role in the pathogenesis of diabetes.
KW - ARIC
KW - Cohort
KW - Diabetes risk
KW - Lactate
UR - http://www.scopus.com/inward/record.url?scp=84888023695&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888023695&partnerID=8YFLogxK
U2 - 10.1016/j.annepidem.2013.09.005
DO - 10.1016/j.annepidem.2013.09.005
M3 - Article
C2 - 24176820
AN - SCOPUS:84888023695
SN - 1047-2797
VL - 23
SP - 791-796.e4
JO - Annals of epidemiology
JF - Annals of epidemiology
IS - 12
ER -